Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 15, 2017BloodOpen Access

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

View Full Paper
Ask AI
Bookmark
Share

Authors

WMWolfgang MiesbachGoethe University FrankfurtKMKarina MeijerVascular MedicineMCMichiel CoppensVascular Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miesbach et al. (2017) studied this question.

synapsesocial.com/papers/6a01c5558d267ec217d8bd71https://doi.org/10.1182/blood-2017-09-804419
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Potential for cellular stress response to hepatic factor VIII expression from AAV vector2016 · 64 citations
  2. 2Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors2010 · 980 citations
  3. 3Diagnosis and management of haemophilia2012 · 108 citations
  4. 4Musculoskeletal Complications of Hemophilia2009 · 4 citations
  5. 5Manufacturing and Characterization of a Recombinant Adeno-Associated Virus Type 8 Reference Standard Material2014 · 94 citations